Interestingly and important for therapy development, during a hepatitis B flare, TNFα- and IFNγ-producing HBV-specific CD4+ T cells could be detected, further indicating that the CD4+ T cells still poses the capability of type I cytokine production when re-activated [64]. Here, CD4 is linked to hepatitis B virus infection.